Background: User-friendly devices for the delivery of asthma drugs are needed to enhance
treatment compliance. Formoterol inhalation powder has been developed to Easyhaler® …

A long-acting β2-agonist (LABA) combined with an inhaled corticosteroid (ICS) is frequently
prescribed as initial therapy in steroid-naïve asthma patients because of its effective control …

This study was designed to compare the bronchodilatatory effect of terbutaline inhaled
through Turbuhaler®(TH) or pressurized metered-dose inhaler (pMDI) in young asthmatics …

Study objectives Inspiratory capacity (IC) has been proposed as a simple method to assess
acute changes in functional residual capacity (FRC) with bronchodilation, assuming that …

Background The primary lung function endpoint in clinical trials in adolescent and adult
patients with asthma is usually forced expiratory volume in one second (FEV 1). The …

BACKGROUND: Extensively used current guidelines of the American Thoracic
Society/European Respiratory Society (ATS/ERS) define a positive aerosolized …

In the present trial, we compared the broncholytic efficacy of the combination therapy with 50
μg salmeterol+ 250 μg fluticasone and 12 μg formoterol+ 400 μg budesonide, both in a …

Bronchodilators remain the mainstay of chronic obstruc-tive pulmonary disease (COPD)
management and are recommended for the treatment of symptomatic patients at all stages …

We tested the hypothesis that heliox breathing, by reducing lung dynamic hyperinflation
(DH) and dyspnea (Dys) sensation, may significantly improve exercise endurance capacity …

Expiratory flow limitation (EFL), which promotes dynamic hyperinflation and increased work
of breathing, often occurs in chronic obstructive pulmonary disease (COPD). The purpose of …